Publications by authors named "Nadia Haidar"
BJUI Compass
November 2022
Article Synopsis
- - The study aimed to test the feasibility of a randomized controlled trial (RCT) examining the effects of aspirin and vitamin D3 in patients with low-risk prostate cancer who are undergoing active surveillance and have undergone Prolaris® testing.
- - Out of 130 eligible patients, 104 (80%) participated, with 94 completing treatment; Prolaris® testing succeeded in 81% of diagnostic biopsies.
- - The findings revealed a 12-month disease progression rate of 43.3% among participants, with high treatment adherence (91%) in non-progressing patients, though there were two serious adverse events linked to aspirin.
